Cure My Disease

Don't miss your cure!

 Log in / Sign up

A new twist on lung rehab: helping the helpers

NCT ID NCT07791147

Disease control Sponsor: Aveiro University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 27, 2026 · Last updated Aug 28, 2026 · Updated 1 time

Summary

This trial tests a new approach to pulmonary rehabilitation, a standard programme of exercise and education for people with chronic lung disease. The twist is that informal carers, often family members, join the education and support sessions. The goal is to see if this carer-inclusive approach helps carers feel more prepared and less burdened. The study will compare 120 patient-carer pairs who get either standard rehabilitation or the carer-inclusive version.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Carer inclusive pulmonary rehabilitation, a 12-week programme with exercise, education, and psychosocial support for patients and their informal carers
What this could lead to
If it works, this could make pulmonary rehabilitation a dual-support tool that helps both patients and the family members who care for them.
What could go wrong
This is a single trial with 120 patient-carer pairs, so results may not apply to everyone. Adding carer sessions could also increase time and effort for families.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 120 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Participants will be recruited as patient-informal carer dyads. Informal carers will be identified by a person with a chronic respiratory disease referred for pulmonary rehabilitation. Inclusion Criteria Informal carers: * Aged 18 years or older. * Providing unpaid informational, physical, practical, emotional, social, or financial support to a person with a chronic respiratory disease. * Identified by the patient as the primary informal carer Patients: * Aged 18 years or older * Diagnosis of chronic obstructive pulmonary disease, interstitial lung disease, bronchiectasis, asthma, or lung cancer. * Clinically stable in the previous month (no changes in medication or occurrence of exacerbations) * Referred for pulmonary rehabilitation. * Report having an informal carer Exclusion Criteria Informal carers: * Unable to provide informed consent * Signs of cognitive impairment Patients: * Unable to provide informed consent * Signs of cognitive impairment * Participated in a pulmonary rehabilitation programme within the last 6 months * Neoplastic or immunological disease, or an unstable or significant cardiac, musculoskeletal, neuromuscular, or psychiatric condition that limits the ability to participate in the pulmonary rehabilitation programme.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Asthma are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

asthma bronchiectasis chronic obstructive pulmonary disease COPD, severe early onset interstitial lung disease lung cancer lung neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Asthma Bronchiectasis Lung diseases, interstitial Lung neoplasms Pulmonary disease, chronic obstructive

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    7 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Laboratório de Investigação e Reabilitação Respiratória da Escola Superior de Saúde da Universidade de Aveiro Lab3R-ESSUA

    Aveiro, 3810-193, Portugal

  • Unidade Local de Saúde Baixo Mondego

    Figueira da Foz Municipality, Coimbra District, 3094-001, Portugal

  • Unidade Local de Saúde Entre o Douro e Vouga

    Santa Maria da Feira, Aveiro District, 4520-211, Portugal

  • Unidade Local de Saúde Região de Aveiro

    Aveiro, Aveiro District, 3814-501, Portugal

  • Unidade Local de Saúde Santa Maria

    Lisbon, Lisbon District, 1649-035, Portugal

  • Unidade Local de Saúde de Gaia e Espinho

    Vila Nova de Gaia, Porto District, 4434-502, Portugal

  • Unidade Local de Saúde de Matosinhos

    Matosinhos Municipality, Porto District, 4464-513, Portugal

More trials for these conditions

Other studies related to the condition(s) this trial covers.